Trade NVNO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
enVVeno Medical Corporation (NVNO) is trading at US$11.10, down 3.39% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$7.03M. Over the past 52 weeks, NVNO has traded between US$0.30 and US$13.44. On Syfe you can trade NVNO with $0 commission and add it to your watchlist.
| Previous close | US$11.49 |
|---|---|
| Market cap | US$7.03M |
| 52-week range | US$0.30 – US$13.44 |
| Volume | 94.42K |
| Exchange | US |
Add to Watchlist
Set Price Alert
enVVeno Medical Corporation
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Year: 2018
--Ladenburg Thalmann Upgrades enVVeno Medical to Buy From Neutral, $30 Price Target
Jul 6, 11:34 AM · MT Newswires
enVVeno Medical Corporation (NVNO) stock is trading at US$11.10, -3.39% from the previous close of US$11.49.
The market cap for enVVeno Medical Corporation (NVNO) stock is approximately US$7.03M.
The 52-week high for enVVeno Medical Corporation (NVNO) stock is US$13.44.
The 52-week low for enVVeno Medical Corporation (NVNO) stock is US$0.30.
enVVeno Medical Corporation (NVNO) does not currently pay a dividend.
Stay on top of NVNO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
